Mineral metabolism
Showing 1 - 25 of 7,470
Osteoporosis, Hypomagnesemia Trial in Dallas (EffCaMgCit, Placebo)
Not yet recruiting
- Osteoporosis
- Hypomagnesemia
- EffCaMgCit
- Placebo
-
Dallas, Texas
- +1 more
Aug 10, 2023
Studies of Inherited Diseases of Metabolism
Completed
- Multiple Endocrine Neoplasia
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 19, 2023
Obesity Trial in Poznan (Plantago major, Placebo)
Completed
- Obesity
- Plantago major
- Placebo
-
Poznań, PolandPoznan University of Life Sciences
Apr 4, 2022
Chronic Kidney Diseases, Bone Diseases, Metabolic Trial in Mansoura (Dapagliflozin 10mg Tab, Placebo)
Active, not recruiting
- Chronic Kidney Diseases
- Bone Diseases, Metabolic
- Dapagliflozin 10mg Tab
- Placebo
-
Mansoura, Aldakahliya, EgyptUrology and Nephrology center, Mansoura University
Feb 16, 2023
Hypoparathyroidism Natural History
Recruiting
- Hypoparathyroidism
-
New York, New YorkColumbia University Medical Center - Harkness Pavillion
Apr 3, 2023
Chronic Kidney Disease Trial in Montpellier, Saint-Jean-de-Védas (Plasma osteoprotegerin level, Plasma fibroblast growth factor
Recruiting
- Chronic Kidney Disease
- Plasma osteoprotegerin level
- +2 more
-
Montpellier, France
- +6 more
Dec 31, 2021
Chronic Kidney Diseases, Osteodystrophy, Uric Acid Concentration, Serum, Quantitative Trait Locus 7 Trial in São Paulo
Recruiting
- Chronic Kidney Diseases
- +2 more
-
São Paulo, SP, BrazilHospital das Clinicas HCFMUSP
Oct 26, 2022
BMD and Ca-P Metabolism in RSA Patients: LMWH Use Versus Control
Recruiting
- Recurrent Spontaneous Abortion
- Low molecular weight heparin
-
Shanghai, Shanghai, ChinaRenji Hospital, Shanghai Jiaotong University School of Medicine
May 18, 2023
Tooth Loss, Vitamin D3 Deficiency, Osteomalacia Trial in Moscow (Dental implantation)
Completed
- Tooth Loss
- +2 more
- Dental implantation
-
Moscow, Russian Federation
- +1 more
Aug 10, 2022
Chronic Kidney Disease-Mineral and Bone Disorder Trial
Completed
- Chronic Kidney Disease-Mineral and Bone Disorder
- (no location specified)
May 29, 2022
Uric Acid Kidney Stone Disease Trial in Dallas (Pioglitazone, Placebo)
Recruiting
- Uric Acid Kidney Stone Disease
- Pioglitazone
- Placebo
-
Dallas, TexasUT Southwestern Medical Center - Center for Mineral Metabolism
Dec 20, 2021
Osteoporosis Trial in Matsumoto ("Teriparatide", "Forteo® or Teribon")
Recruiting
- Osteoporosis
- "Teriparatide", "Forteo® or Teribon"
-
Matsumoto, Nagano, JapanYukio Nakamura
Sep 20, 2021
Effects of the Elements Trial (PMA-zeolite)
Completed
- Effects of the Elements
- PMA-zeolite
- (no location specified)
Oct 27, 2020
Bone Metabolism Trial in Boston (testosterone cypionate)
Withdrawn
- Bone Metabolism
- testosterone cypionate
-
Boston, MassachusettsMassachusetts General Hospital
Oct 22, 2021
Osteoporosis Trial in Matsumoto (Ibandronate, Oral Ibandronate and Vitamin D)
Recruiting
- Osteoporosis
- Ibandronate
- Oral Ibandronate and Vitamin D
-
Matsumoto, Nagano, JapanYukio Nakamura
Sep 20, 2021
Chronic Renal Insufficiency, Renal Osteodystrophy Trial in Hefei, Nanjing, Shanghai
Recruiting
- Chronic Renal Insufficiency
- Renal Osteodystrophy
-
Hefei, Anhui, China
- +3 more
Sep 21, 2021
Osteoporosis Trial in Matsumoto ("Zoledronic acid", "Reclast®", "Zoledronic acid", "Reclast®" and "active vitamin D",
Recruiting
- Osteoporosis
- "Zoledronic acid", "Reclast®"
- "Zoledronic acid", "Reclast®" and "active vitamin D", "alfacalcidol®"
-
Matsumoto, Nagano, JapanYukio Nakamura
Sep 20, 2021
Bone Metabolism Biomarkers, Bone Mineral Density, Physical Fitness Trial in Rochester (Vitamin D3, Physical Activity)
Active, not recruiting
- Bone Metabolism Biomarkers
- +2 more
- Vitamin D3
- Physical Activity
-
Rochester, New YorkUniversity of Rochester
Nov 4, 2021
BMD Alterations and Bone and Muscle Parameters During Menstrual
Completed
- Endometriosis
- +3 more
- Goserelin Acetate
-
Thessaloníki, Greece424 General Military Hospital
Jan 11, 2021
Uric Acid Nephrolithiasis Trial in Dallas (123I-BMIPP, 99mTc-MAG3)
Withdrawn
- Uric Acid Nephrolithiasis
- 123I-BMIPP
- 99mTc-MAG3
-
Dallas, Texas
- +1 more
Oct 1, 2020
Markers of Metabolism and Vascular Access in ESRD
Not yet recruiting
- Disorders of Calcium and Bone Metabolism
- vascular acess
- (no location specified)
May 2, 2023
Chronic Kidney Disease Stage 5, Mineral Metabolism Disorder Trial in Herlev (High phosphorous containing meal, Low phosphorous
Completed
- Chronic Kidney Disease Stage 5
- Mineral Metabolism Disorder
- High phosphorous containing meal
- Low phosphorous containing meal
-
Herlev, DenmarkHerlev Hospital
Aug 13, 2019
End Stage Renal Disease on Dialysis Trial in New Taipei City (Therapeutic diet)
Completed
- End Stage Renal Disease on Dialysis
- Therapeutic diet
-
New Taipei City, TaiwanFar Eastern Memorial Hospital
Mar 15, 2022
Myocardial Infarction Trial in Spain (Calcifediol, Placebo)
Active, not recruiting
- Myocardial Infarction
- Calcifediol
- Placebo
-
Fuenlabrada, Madrid, Spain
- +6 more
Aug 26, 2022